X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (40751) 40751
Book Review (8394) 8394
Publication (2147) 2147
Book Chapter (384) 384
Newsletter (357) 357
Newspaper Article (155) 155
Magazine Article (137) 137
Conference Proceeding (72) 72
Book / eBook (51) 51
Dissertation (27) 27
Trade Publication Article (23) 23
Reference (11) 11
Paper (8) 8
Data Set (5) 5
Government Document (2) 2
Web Resource (2) 2
Journal / eJournal (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (33835) 33835
humans (33255) 33255
female (19868) 19868
male (18565) 18565
middle aged (14275) 14275
adult (12916) 12916
aged (10770) 10770
thrombosis (9851) 9851
venous thrombosis (9503) 9503
risk factors (9493) 9493
venous thromboembolism (9253) 9253
hematology (9146) 9146
peripheral vascular disease (8672) 8672
surgery (6749) 6749
thromboembolism (6718) 6718
treatment outcome (4972) 4972
deep-vein thrombosis (4636) 4636
anticoagulants - therapeutic use (4572) 4572
abridged index medicus (4520) 4520
retrospective studies (4399) 4399
venous thrombosis - etiology (4357) 4357
aged, 80 and over (4346) 4346
adolescent (4113) 4113
risk (3928) 3928
anticoagulants (3773) 3773
prevention (3773) 3773
diagnosis (3679) 3679
pulmonary embolism (3663) 3663
medicine & public health (3334) 3334
care and treatment (3174) 3174
prospective studies (3166) 3166
pulmonary-embolism (2941) 2941
medicine, general & internal (2889) 2889
venous thrombosis - diagnosis (2826) 2826
risk-factors (2743) 2743
time factors (2612) 2612
health aspects (2581) 2581
deep venous thrombosis (2555) 2555
management (2531) 2531
analysis (2504) 2504
young adult (2503) 2503
complications (2493) 2493
animals (2434) 2434
blood clot (2418) 2418
cancer (2412) 2412
venous thrombosis - drug therapy (2368) 2368
molecular-weight heparin (2318) 2318
child (2312) 2312
research (2242) 2242
disease (2211) 2211
venous thrombosis - prevention & control (2179) 2179
follow-up studies (2168) 2168
incidence (2128) 2128
venous thrombosis - diagnostic imaging (2119) 2119
pregnancy (2099) 2099
radiology, nuclear medicine & medical imaging (2060) 2060
anticoagulants - administration & dosage (1981) 1981
risk assessment (1981) 1981
mortality (1955) 1955
deep vein thrombosis (1923) 1923
oncology (1913) 1913
mutation (1907) 1907
heparin (1881) 1881
venous thrombosis - complications (1864) 1864
catheterization, central venous - adverse effects (1840) 1840
case-control studies (1789) 1789
venous thrombosis - blood (1788) 1788
cardiac & cardiovascular systems (1783) 1783
venous thrombosis - epidemiology (1776) 1776
therapy (1769) 1769
prevalence (1743) 1743
patients (1723) 1723
tomography, x-ray computed (1720) 1720
recurrence (1666) 1666
thrombophilia (1665) 1665
pediatrics (1664) 1664
anticoagulants - adverse effects (1642) 1642
clinical neurology (1629) 1629
ultrasonography (1626) 1626
prophylaxis (1588) 1588
venous thromboembolism - prevention & control (1582) 1582
coagulation (1567) 1567
prognosis (1549) 1549
warfarin (1493) 1493
venous thromboembolism - etiology (1475) 1475
factor-v-leiden (1461) 1461
child, preschool (1455) 1455
thrombosis - etiology (1437) 1437
children (1423) 1423
drug therapy (1423) 1423
medical research (1412) 1412
cohort studies (1397) 1397
activated protein-c (1364) 1364
hematology, oncology and palliative medicine (1360) 1360
factor v - genetics (1350) 1350
complications and side effects (1342) 1342
veins & arteries (1341) 1341
usage (1331) 1331
venous thrombosis - therapy (1325) 1325
stroke (1324) 1324
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (40072) 40072
German (401) 401
French (389) 389
Spanish (177) 177
Russian (174) 174
Chinese (141) 141
Japanese (131) 131
Italian (56) 56
Polish (47) 47
Portuguese (36) 36
Turkish (36) 36
Korean (33) 33
Dutch (23) 23
Danish (22) 22
Czech (21) 21
Hungarian (18) 18
Swedish (15) 15
Ukrainian (12) 12
Croatian (10) 10
Finnish (10) 10
Serbian (9) 9
Hebrew (6) 6
Norwegian (6) 6
Slovak (4) 4
Bulgarian (3) 3
Lithuanian (3) 3
Romanian (3) 3
Arabic (2) 2
Persian (2) 2
Bosnian (1) 1
Macedonian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e419S - e496S
Background: This article addresses the treatment of VTE disease. Methods: We generated strong (Grade 1) and weak (Grade 2) recommendations based on... 
RIGHT-VENTRICULAR DYSFUNCTION | RECURRENT VENOUS THROMBOEMBOLISM | TISSUE-PLASMINOGEN-ACTIVATOR | RESPIRATORY SYSTEM | ACUTE PULMONARY-EMBOLISM | MOLECULAR-WEIGHT HEPARIN | VENA-CAVA FILTER | ORAL ANTICOAGULANT-THERAPY | INTRAVENOUS UNFRACTIONATED HEPARIN | LONG-TERM TREATMENT | DEEP-VEIN-THROMBOSIS | CRITICAL CARE MEDICINE | Venous Thrombosis - diagnosis | Pulmonary Embolism - prevention & control | United States | Humans | Venous Thrombosis - blood | Heparin, Low-Molecular-Weight - adverse effects | Hemorrhage - prevention & control | Long-Term Care | Heparin, Low-Molecular-Weight - therapeutic use | Fibrinolytic Agents - adverse effects | Vitamin K - antagonists & inhibitors | Societies, Medical | Fibrinolytic Agents - therapeutic use | Venous Thrombosis - prevention & control | Polysaccharides - therapeutic use | Drug Administration Schedule | Venous Thrombosis - drug therapy | Administration, Oral | Risk Factors | Polysaccharides - adverse effects | Anticoagulants - therapeutic use | Hemorrhage - blood | Anticoagulants - adverse effects | Evidence-Based Medicine | Pulmonary Embolism - blood | International Normalized Ratio | Diagnostic Imaging | Pulmonary Embolism - diagnosis | Pulmonary Embolism - drug therapy | Hemorrhage - chemically induced | Infusions, Intravenous | Index Medicus | Abridged Index Medicus | Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed | American College of Chest Physician Evidence-Based Clinical Practice Guidelines Online Only
Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 03/2007, Volume 5, Issue 3, pp. 520 - 527
Background:  Cancer, in particular mucinous adenocarcinoma, is associated with venous thromboembolism (VTE). Tissue factor (TF), initiator of coagulation,... 
nanoparticles | tissue factor | neoplasms | breast‐neoplasms | pancreatic neoplasms | venous thrombosis | Nanoparticles | Breast-neoplasms | Venous thrombosis | Neoplasms | Pancreatic neoplasms | Tissue factor | CELLS | MEMBRANE MICROPARTICLES | METASTASIS | PANCREATIC-CANCER | FACTOR EXPRESSION | breast-neoplasms | CELLULAR MICROPARTICLES | P-SELECTIN | COAGULATION | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | BLOOD | Predictive Value of Tests | Prognosis | Follow-Up Studies | Adenocarcinoma, Mucinous - pathology | Humans | Middle Aged | Venous Thrombosis - blood | Male | Case-Control Studies | Likelihood Functions | Time Factors | Adenocarcinoma, Mucinous - blood | Antigens, Neoplasm - blood | Blood Coagulation | Cytoplasmic Vesicles - metabolism | Adult | Female | Cell Differentiation | Pancreatic Neoplasms - mortality | Adenocarcinoma, Mucinous - complications | Pancreatic Neoplasms - blood | Risk Assessment | Neoplasm Invasiveness | Pancreatic Neoplasms - pathology | Kaplan-Meier Estimate | Proportional Hazards Models | Venous Thrombosis - mortality | Thromboembolism - etiology | Thromboembolism - mortality | Venous Thrombosis - etiology | Mucin-1 | Mucins - blood | Adenocarcinoma, Mucinous - mortality | Breast Neoplasms - complications | Thromboembolism - blood | Breast Neoplasms - pathology | Breast Neoplasms - blood | Breast Neoplasms - mortality | Aged | Thromboplastin - metabolism | Neoplasm Staging | Pancreatic Neoplasms - complications | Index Medicus
Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 10/2011, Volume 50, Issue 10, pp. 675 - 686
Background and Objective: Rivaroxaban is an oral, direct Factor Xa inhibitor, which is at an advanced stage of clinical development for prevention and... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Dose-prediction | Rivaroxaban | Pharmacodynamic-modelling | Atrial-fibrillation | Deep-vein-thrombosis | Population- pharmacokinetics | Factor-Xa-inhibitors | Antithrombotics | Pharmacology | Pharmacokinetic-pharmacodynamic-relationships | Pharmacokinetic-modelling | ENOXAPARIN | IN-VITRO | FACTOR-XA INHIBITOR | BAY-59-7939 | MANAGEMENT | VENOUS THROMBOEMBOLISM | METABOLISM | ARTHROPLASTY | PHARMACOLOGY & PHARMACY | PHARMACODYNAMICS | THROMBOPROPHYLAXIS | Body Weight | Age Factors | Anticoagulants - administration & dosage | Factor Xa Inhibitors | Humans | Middle Aged | Venous Thrombosis - blood | Male | Thiophenes - administration & dosage | Morpholines - blood | Thiophenes - blood | Young Adult | Computer Simulation | Aged, 80 and over | Adult | Female | Acute Disease | Stroke - prevention & control | Venous Thrombosis - drug therapy | Administration, Oral | Atrial Fibrillation - drug therapy | Morpholines - administration & dosage | Morpholines - pharmacology | Thiophenes - pharmacology | Anticoagulants - blood | Atrial Fibrillation - blood | Stroke - blood | Thiophenes - pharmacokinetics | Models, Biological | Anticoagulants - pharmacology | Adolescent | Aged | Anticoagulants - pharmacokinetics | Morpholines - pharmacokinetics | Index Medicus
Journal Article
Blood, ISSN 0006-4971, 09/2015, Volume 126, Issue 11, pp. 1379 - 1389
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e601S - e636S
Objectives: This article provides recommendations on the use of antithrombotic therapy in patients with stroke or transient ischemic attack (TIA). Methods: We... 
HIGH-RISK PATIENTS | TISSUE-PLASMINOGEN ACTIVATOR | CEREBRAL VENOUS THROMBOSIS | PATENT FORAMEN OVALE | RESPIRATORY SYSTEM | LONG-TERM SURVIVAL | LOW-MOLECULAR-WEIGHT | DEEP-VEIN THROMBOSIS | ASPIRIN PLUS DIPYRIDAMOLE | NONVALVULAR ATRIAL-FIBRILLATION | EXTENDED-RELEASE DIPYRIDAMOLE | CRITICAL CARE MEDICINE | Recombinant Proteins - therapeutic use | United States | Humans | Heparin - therapeutic use | Tissue Plasminogen Activator - therapeutic use | Intracranial Thrombosis - prevention & control | Recombinant Proteins - adverse effects | Heparin - adverse effects | Tissue Plasminogen Activator - adverse effects | Dose-Response Relationship, Drug | Fibrinolytic Agents - adverse effects | Societies, Medical | Aspirin - adverse effects | Fibrinolytic Agents - therapeutic use | Ischemic Attack, Transient - etiology | Aspirin - therapeutic use | Intracranial Thrombosis - drug therapy | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Stroke - prevention & control | Ischemic Attack, Transient - drug therapy | Intermittent Pneumatic Compression Devices | Intracranial Thrombosis - blood | Combined Modality Therapy | Stroke - drug therapy | Evidence-Based Medicine | Stroke - blood | Intracranial Thrombosis - etiology | Thrombolytic Therapy | Ischemic Attack, Transient - blood | Index Medicus | Abridged Index Medicus | Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed | American College of Chest Physician Evidence-Based Clinical Practice Guidelines Online Only
Journal Article
Journal Article
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2009, Volume 51, Issue 4, pp. 682 - 689
Journal Article